Lirilumab ELISA Kit (DW759018)

Обзор

Каталожный номер	DW759018
Описание	Lirilumab ELISA Kit (DW759018) — Quantitative sandwich ELISA for Lirilumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml. Highlights ●Sandwich Format — High specificity, reliable quantification. ●High Sensitivity — Optimized for low-abundance target detection. ●Ready-to-Use — Complete kit with pre-coated plates included.
Тип образца	Plasma, Serum
Чувствительность	0.156 μg/ml
Диапазон	0.31-5 μg/mL
Применения	ELISA
Метод обнаружения	Colorimetric
Тип анализа	Quantitative
Восстановление	80-120%
Доставка	2-8 ℃
Устойчивость и хранение	The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Характеристики	Lirilumab
Альтернативные названия	BMS-986015, IPH2102, 1000676-41-4
Фон	Lirilumab (IPH2102/BMS-986015/BMS-986015-01) is a fully human monoclonal antibody (mAb) that is designed to block the interaction between KIR2DL-1, -2, -3 inhibitory receptors and their ligands. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb. A phase 2 clinical trial for acute myeloid leukemia (AML) was terminated early (
Примечание	For Research Use Only.